The cost-effectiveness of basiliximab induction in "old-to-old" kidney transplant programs: Bayesian estimation, simulation, and uncertainty analysis.

@article{Emparan2005TheCO,
  title={The cost-effectiveness of basiliximab induction in "old-to-old" kidney transplant programs: Bayesian estimation, simulation, and uncertainty analysis.},
  author={Carlos Emparan and Heiner Hubert Wolters and M Lauk{\"o}tte and Norbert Senninger},
  journal={Transplantation proceedings},
  year={2005},
  volume={37 5},
  pages={2069-71}
}
INTRODUCTION Markov models are employed in economic analyses to evaluate all possible expectations in a dilemna. The introduction of a new clinical protocol (Basiliximab induction with calcineurin-sparing protocols) for a group of kidney transplant recipients receiving organs from marginal donors was validated with a Markov simulation model, demonstrating the usefulness of combining simulation with Bayesian estimation methods for analysis of cost-effectiveness data collected alongside a… CONTINUE READING